Literature DB >> 12028455

Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.

Claude Braun1, Thomas Kleemann, Ulrich Hilgenfeldt, Udo Riester, Peter Rohmeiss, Fokko J van der Woude.   

Abstract

UNLABELLED: Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
BACKGROUND: The kallikrein-kinin-system is a complex multienzymatic system that has been implicated in the control of systemic blood pressure, glomerular filtration rate, and proteinuria. The present study investigated its functional role in rat polycystic kidney disease (PKD), which is characterized by progressive renal failure and proteinuria in the absence of systemic hypertension and stimulated renin-angiotensin-system.
METHODS: Kallikrein and bradykinin levels were measured in plasma and urine of rats with polycystic kidneys and compared to non-affected controls (SD) and rats with reduced renal mass. The functional relevance of the kallikrein-kinin system (KKS) was assessed by the effects of a short-term treatment with either a selective bradykinin (BK) B1-receptor antagonist (des-Arg9-[Leu8]-BK), a B2-receptor antagonist (HOE 140), an angiotensin converting enzyme inhibitor (ramipril), or an angiotensin II-receptor blocker (HR 720) on systemic and renal parameters.
RESULTS: Urine levels of kallikrein were increased threefold in 9-month-old PKD, and BK excretion was increased tenfold in 3-month and 30-fold in 9-month-old PKD compared to age-matched SD rats. Blood pressure in 9-month-old PKD rats was decreased to the same degree by ramipril and HR 720. In contrast, only ramipril and HOE 140 significantly reduced proteinuria and albuminuria, independent from creatinine clearance. This effect was accompanied by an increased excretion of bradykinin. The B1 receptor antagonist had no influence on functional renal parameters.
CONCLUSIONS: The present study demonstrates an age-dependent activation of the renal KKS in rats with polycystic kidney disease. The bradykinin B2-receptor is involved in the pathogenesis of proteinuria, independent from systemic blood pressure or creatinine clearance. The antiproteinuric effect of ramipril in this model is angiotensin II-independent and related to its influence on the renal KKS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12028455     DOI: 10.1046/j.1523-1755.2002.00385.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  Exogenous pancreatic kininogenase protects against renal fibrosis in rat model of unilateral ureteral obstruction.

Authors:  Ji-Zhe Jin; Hui-Ying Li; Jian Jin; Shang-Guo Piao; Xiong-Hu Shen; Yan-Ling Wu; Jia-Chong Xu; Long-Ye Zhang; Yu-Ji Jiang; Hai-Lan Zheng; Ying-Shun Jin; Sheng Cui; Kang Luo; Yi Quan; Can Li
Journal:  Acta Pharmacol Sin       Date:  2020-04-16       Impact factor: 6.150

Review 2.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

Review 3.  Recent advances in understanding the pathogenesis of polycystic kidney disease: therapeutic implications.

Authors:  Benjamin D Cowley
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 4.  The kallikrein-kinin system in health and in diseases of the kidney.

Authors:  Masao Kakoki; Oliver Smithies
Journal:  Kidney Int       Date:  2009-02-04       Impact factor: 10.612

5.  Balance between the two kinin receptors in the progression of experimental focal and segmental glomerulosclerosis in mice.

Authors:  Rafael Luiz Pereira; Raphael José Ferreira Felizardo; Marcos Antônio Cenedeze; Meire Ioshie Hiyane; Enio José Bassi; Mariane Tami Amano; Clarice Sylvia Taemi Origassa; Reinaldo Correia Silva; Cristhiane Fávero Aguiar; Sylvia Mendes Carneiro; João Bosco Pesquero; Ronaldo Carvalho Araújo; Alexandre de Castro Keller; Renato C Monteiro; Ivan Cruz Moura; Alvaro Pacheco-Silva; Niels Olsen Saraiva Câmara
Journal:  Dis Model Mech       Date:  2014-04-17       Impact factor: 5.758

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.